DE60318608D1 - Ptprk-immunogenes peptid - Google Patents

Ptprk-immunogenes peptid

Info

Publication number
DE60318608D1
DE60318608D1 DE60318608T DE60318608T DE60318608D1 DE 60318608 D1 DE60318608 D1 DE 60318608D1 DE 60318608 T DE60318608 T DE 60318608T DE 60318608 T DE60318608 T DE 60318608T DE 60318608 D1 DE60318608 D1 DE 60318608D1
Authority
DE
Germany
Prior art keywords
ptprk
immunogenic peptide
diagnosis
cells
cancer immunotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60318608T
Other languages
English (en)
Other versions
DE60318608T2 (de
Inventor
Chiara Castelli
Giorgio Parmiani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per lo Studio e la Cura die Tumori
Original Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Nazionale per lo Studio e la Cura die Tumori filed Critical Istituto Nazionale per lo Studio e la Cura die Tumori
Publication of DE60318608D1 publication Critical patent/DE60318608D1/de
Application granted granted Critical
Publication of DE60318608T2 publication Critical patent/DE60318608T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60318608T 2002-11-14 2003-11-12 Ptprk-immunogenes peptid Expired - Fee Related DE60318608T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002412A ITMI20022412A1 (it) 2002-11-14 2002-11-14 Peptidi immunogeni di ptprk.
ITMI20022412 2002-11-14
PCT/EP2003/012638 WO2004043988A2 (en) 2002-11-14 2003-11-12 Ptprk immunogenic peptide

Publications (2)

Publication Number Publication Date
DE60318608D1 true DE60318608D1 (de) 2008-02-21
DE60318608T2 DE60318608T2 (de) 2009-01-15

Family

ID=32310164

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318608T Expired - Fee Related DE60318608T2 (de) 2002-11-14 2003-11-12 Ptprk-immunogenes peptid

Country Status (12)

Country Link
US (1) US20060159691A1 (de)
EP (1) EP1560848B1 (de)
JP (1) JP2006506064A (de)
AT (1) ATE383371T1 (de)
AU (1) AU2003293677A1 (de)
DE (1) DE60318608T2 (de)
DK (1) DK1560848T3 (de)
ES (1) ES2299748T3 (de)
HK (1) HK1076476A1 (de)
IT (1) ITMI20022412A1 (de)
PT (1) PT1560848E (de)
WO (1) WO2004043988A2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863755A (en) * 1993-04-21 1999-01-26 Max Planck Gessellschaft Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ

Also Published As

Publication number Publication date
WO2004043988A8 (en) 2005-08-25
JP2006506064A (ja) 2006-02-23
HK1076476A1 (en) 2006-01-20
EP1560848A2 (de) 2005-08-10
DE60318608T2 (de) 2009-01-15
ITMI20022412A1 (it) 2004-05-15
WO2004043988A2 (en) 2004-05-27
DK1560848T3 (da) 2008-05-26
AU2003293677A1 (en) 2004-06-03
PT1560848E (pt) 2008-04-08
EP1560848B1 (de) 2008-01-09
ATE383371T1 (de) 2008-01-15
ES2299748T3 (es) 2008-06-01
US20060159691A1 (en) 2006-07-20
WO2004043988A3 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
CY1113044T1 (el) Παραλλαγματα αντιγονου αρχεγονων κυτταρων προστατη (psca) και υποαλληλουχιες εξ αυτων
PE20040554A1 (es) Vacunas que comprenden proteinas de fusion
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
CR8231A (es) Anticuerpos rg1 y uso de los mismos
DE602004025943D1 (de) Mikrosomvakzin
EA200501206A1 (ru) Производные от сурвивина пептиды и их применение
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DK0810870T3 (da) Isolerede, MAGE-2-afledte tumorafstødelsesantigenpræcurserpeptider og anvendelse heraf
CY1106789T1 (el) Γενικος φορεας για στοχευση μοριων σε κυτταρα που εκφραζουν gb3 υποδοχεα
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
ATE457352T1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
AU2003242535A1 (en) Improved polysaccharide and glycoconjugate vaccines
WO1999064464A3 (en) Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
DE60118359D1 (de) Humanische pellino-polypeptide
ATE234628T1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
AU2003241127A1 (en) MEMBRANE-ANCHORED Beta2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
AU7615900A (en) Isolated peptides which bind to mhc class ii molecules, and uses thereof
DK1560848T3 (da) PTPRK-immunogent peptid
GB0203419D0 (en) Peptide
AU2003245781A1 (en) Mhc class ii peptide epitope of 5t4 antigen
EP2193804A3 (de) Rekombinantes Adenylat-Cyclase-Toxin von Bordetella induziert T-Zell-Antworten gegen tumorale Antigene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee